MA
TEVA icon

MCF Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

MCF Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$2.02K – 1182
2025
Q3 		$2.02K Hold
100
– – ﹤0.01% 886
2025
Q2 		$1.68K Hold
100
– – ﹤0.01% 821
2025
Q1 		$1.54K Hold
100
– – ﹤0.01% 826
2024
Q4 		$2.2K Hold
100
– – ﹤0.01% 839
2024
Q3 		$1.8K Hold
100
– – ﹤0.01% 851
2024
Q2 		$1.63K Buy
+100
New +$1.54K ﹤0.01% 868
2017
Q3 		– Sell
-1,303
Closed -$43K – 538
2017
Q2 		$43K Hold
1,303
– – 0.01% 242
2017
Q1 		$42K Sell
1,303
-227
-15% -$7.75K 0.01% 244
2016
Q4 		$55K Buy
1,530
+500
+49% +$20K 0.01% 200
2016
Q3 		$47K Hold
1,030
– – 0.01% 210
2016
Q2 		$52K Sell
1,030
-27
-3% -$1.44K 0.01% 222
2016
Q1 		$57K Sell
1,057
-180
-15% -$10.6K 0.01% 176
2015
Q4 		$81K Hold
1,237
– – 0.02% 141
2015
Q3 		$70K Buy
1,237
+178
+17% +$11.5K 0.02% 160
2015
Q2 		$63K Buy
1,059
+227
+27% +$14K 0.02% 164
2015
Q1 		$52K Hold
832
– – 0.01% 186
2014
Q4 		$48K Hold
832
– – 0.01% 176
2014
Q3 		$44K Hold
832
– – 0.01% 188
2014
Q2 		$44K Hold
832
– – 0.01% 187
2014
Q1 		$44K Hold
832
– – 0.01% 195
2013
Q4 		$44K Sell
832
-25
-3% -$984 0.02% 176
2013
Q3 		$45K Buy
857
+677
+376% +$26.4K 0.02% 179
2013
Q2 		$10K Buy
+180
New +$7.01K 0.01% 243

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

MCF Advisors's TEVA Position: Q4 2025 in Review

MCF Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2025, closing a stake of 100 shares — an estimated $2.02K sold.

MCF Advisors first reported a position in TEVA in Q2 2013 and held it in 23 quarters. The position peaked at $81K in Q4 2015. 631 funds tracked by Wall St. Rank hold TEVA as of Q4 2025.

  • MCF Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • MCF Advisors sold 100 Teva Pharmaceuticals shares in Q4 2025, an estimated $2.02K.
  • MCF Advisors first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 23 quarters.
  • MCF Advisors's Teva Pharmaceuticals position peaked at $81K in Q4 2015.
  • 631 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2025.

Based on MCF Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.